Donald S. Beyer, Jr. bought VanEck Biotech ETF (BBH) [ST] F ILINg S TATUS : New S UBHOLDINg O F : Stocks, Bonds, & Mutual Funds D ESCRIPTION : purchase 17 shares Vaneck Trust Biotech (BBH)
Donald S. Beyer, Jr. (D-VA), a U.S. Representative, has disclosed 2 trades in VanEck Biotech ETF (BBH) [ST] F ILINg S TATUS : New S UBHOLDINg O F : Stocks, Bonds, & Mutual Funds D ESCRIPTION : purchase 17 shares Vaneck Trust Biotech (BBH) since 2021, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Donald S. Beyer, Jr. bought $1,001 - $15,000 of VanEck Biotech ETF (BBH) [ST] F ILINg S TATUS : New S UBHOLDINg O F : Stocks, Bonds, & Mutual Funds D ESCRIPTION : purchase 17 shares Vaneck Trust Biotech (BBH) on December 22, 2021. Since that trade, BBH is up +12.14% against the S&P 500 up +65.34%, an outperformance of -53.21%.
Across these filings, Donald S. Beyer, Jr. has been a balanced trader of BBH (a buy-to-sell ratio of 1.00). The most recent disclosed BBH transaction shown was dated January 28, 2022. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Donald S. Beyer, Jr.'s BBH trades vs the price
BBH is up +12.14% since Donald S. Beyer, Jr. bought on December 22, 2021, versus +65.34% for the S&P 500.
Performance since this trade
All Donald S. Beyer, Jr. BBH trades
Donald S. Beyer, Jr. & BBH trading FAQ
Is it legal for Donald S. Beyer, Jr. to trade VanEck Biotech ETF (BBH) [ST] F ILINg S TATUS : New S UBHOLDINg O F : Stocks, Bonds, & Mutual Funds D ESCRIPTION : purchase 17 shares Vaneck Trust Biotech (BBH) stock?
Yes. Members of Congress are allowed to trade individual stocks, including VanEck Biotech ETF (BBH) [ST] F ILINg S TATUS : New S UBHOLDINg O F : Stocks, Bonds, & Mutual Funds D ESCRIPTION : purchase 17 shares Vaneck Trust Biotech (BBH), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Donald S. Beyer, Jr. buy BBH?
Donald S. Beyer, Jr. disclosed a purchase of $1,001 - $15,000 of VanEck Biotech ETF (BBH) [ST] F ILINg S TATUS : New S UBHOLDINg O F : Stocks, Bonds, & Mutual Funds D ESCRIPTION : purchase 17 shares Vaneck Trust Biotech (BBH) on December 22, 2021, according to public STOCK Act filings.
How has BBH performed since Donald S. Beyer, Jr.'s trade?
Since Donald S. Beyer, Jr. bought BBH on December 22, 2021, the stock is up +12.14%, versus +65.34% for the S&P 500 over the same period, an outperformance of -53.21%.
How many times has Donald S. Beyer, Jr. traded BBH?
Donald S. Beyer, Jr. has disclosed 2 BBH trades since 2021 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BBH trades?
Quantellect tracks every disclosed congressional trade in VanEck Biotech ETF (BBH) [ST] F ILINg S TATUS : New S UBHOLDINg O F : Stocks, Bonds, & Mutual Funds D ESCRIPTION : purchase 17 shares Vaneck Trust Biotech (BBH) on the VanEck Biotech ETF (BBH) [ST] F ILINg S TATUS : New S UBHOLDINg O F : Stocks, Bonds, & Mutual Funds D ESCRIPTION : purchase 17 shares Vaneck Trust Biotech congressional trading page, which aggregates filings across all members of Congress.
Donald S. Beyer, Jr.'s BBH tradesAll congressional filings for VanEck Biotech ETF (BBH) [ST] F ILINg S TATUS : New S UBHOLDINg O F : Stocks, Bonds, & Mutual Funds D ESCRIPTION : purchase 17 shares Vaneck Trust BiotechDonald S. Beyer, Jr.'s full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.